Experienced in Median Arcuate Ligament Syndrome (MALS)

Dr. Scott A. Celinski

Surgical Oncology | General Surgery
Baylor Scott & White Health
Texas Oncology, P.A.
3410 Worth Street, Suite 160, 
Dallas, TX 
Offers Telehealth
24 Years of Experience

Experienced in Median Arcuate Ligament Syndrome (MALS)
Baylor Scott & White Health
Texas Oncology, P.A.
3410 Worth Street, Suite 160, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Scott Celinski is a Surgical Oncologist and a General Surgeon in Dallas, Texas. Dr. Celinski has been practicing medicine for over 24 years and is rated as an Experienced provider by MediFind in the treatment of Median Arcuate Ligament Syndrome (MALS). His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy.

His clinical research consists of co-authoring 10 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Baylor College Of Medicine, 2002.0
Residency
General Surgery, George Washington University
Specialties
Surgical Oncology
General Surgery
Licenses
Surgery in PA
Fellowships
Critical Care Medicine, George Washington University
Critical Care, George Washington University Hospital
Surgical Oncology, University of Pittsburgh Medical Center GME
Hepatobiliary Surgery, University Of Pittsburgh School of Medicine HR
Surgical Oncology, University Of Pittsburgh School of Medicine HR
Hospital Affiliations
Baylor University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Scott and White Health
  • HMO
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Texas Oncology, P.A.
3410 Worth Street, Suite 160, Dallas, TX 75246
Call: 972-449-0540

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

A Pilot Study of Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Resectable or Potentially Resectable Pancreatic Adenocarcinoma (PDAC)
A Pilot Study of Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Resectable or Potentially Resectable Pancreatic Adenocarcinoma (PDAC)
Enrollment Status: Completed
Publish Date: June 22, 2021
Intervention Type: Drug
Study Phase: Early Phase 1
A Phase I, Safety Trial of Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer
A Phase I, Safety Trial of Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer
Enrollment Status: Terminated
Publish Date: January 29, 2019
Intervention Type: Biological
Study Phase: Phase 1
View 1 Less Clinical Trial

11 Total Publications

Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
Journal: JAMA
Published: April 20, 2023
View All 11 Publications
Similar Doctors
Timothy C. Oskin
Distinguished in Median Arcuate Ligament Syndrome (MALS)
Dr. Timothy C. Oskin
Vascular Surgery | General Surgery
Distinguished in Median Arcuate Ligament Syndrome (MALS)
Dr. Timothy C. Oskin
Vascular Surgery | General Surgery

Texas Health Vascular Surgical Specialists

1325 Pennsylvania Ave, Ste 200, 
Fort Worth, TX 
 (32.7 miles away)
817-250-4235
Languages Spoken:
English
See accepted insurances

Dr. Timothy Oskin joins Texas Health Physicians Group as a board-certified vascular surgeon with 24 years of experience. He acted as division chief of vascular surgery at a busy regional health system, St. Luke's University Health Network, in Pennsylvania and New Jersey. In this role he acted as leader of the vascular program that grew from 3 hospitals to 12 facilities and started an independent medical school while overseeing 9 vascular surgeons as they developed a vascular fellowship. He focused on the improvement of quality patient care with the development of practice guidelines and protocols benchmarked by a national registry.Dr. Oskin earned his medical degree from Hahnemann University School of Medicine in Philadelphia. He then completed a general surgery residency at Washington Hospital Center in Washington, DC followed by specialty training in Vascular Surgery at Wake Forest University in Winston-Salem, NC. After joining a vascular practice in Pennsylvania, he returned to pursue further specialty training by completing an Endovascular Fellowship at the University of Maryland in Baltimore, MD. This has allowed Dr. Oskin to treat a broad range of vascular patients with a combination of medical, endovascular and/or surgical therapies to optimize their outcomes and quality of life.Dr. Oskin offers a vast experience in treatment of all vascular disorders with minimally invasive techniques. To maintain this high level of care he has acted as a principal investigator in numerous clinical trials in the treatment of cerebrovascular disease with minimally invasive stenting technologies, aortic aneurysmal disease with minimally invasive stent grafts and peripheral vascular disease with endovascular technologies. In addition, he served as adjunct clinical assistant professor of Surgery at Temple, Drexel and DeSales Universities which allowed him to educate upcoming medical students, surgical residents and physician assistants.Dr. Oskin remains active as a member of the American College of Surgery, the Southern Association of Vascular Surgery and the Society of Vascular Surgery. Dr. Oskin is rated as a Distinguished provider by MediFind in the treatment of Median Arcuate Ligament Syndrome (MALS). His top areas of expertise are Carotid Artery Disease, Arterial Embolism, Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm, and Carotid Artery Surgery.

Melissa L. Kirkwood
Distinguished in Median Arcuate Ligament Syndrome (MALS)
Dr. Melissa L. Kirkwood
Vascular Surgery | General Surgery
Distinguished in Median Arcuate Ligament Syndrome (MALS)
Dr. Melissa L. Kirkwood
Vascular Surgery | General Surgery

UT Southwestern - Vascular Surgery

2001 Inwood Rd, 5th Fl, 
Dallas, TX 
 (4.3 miles away)
214-645-0538
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Melissa Kirkwood is a General Surgeon and a Vascular Surgeon in Dallas, Texas. Dr. Kirkwood is rated as a Distinguished provider by MediFind in the treatment of Median Arcuate Ligament Syndrome (MALS). Her top areas of expertise are Thoracic Aortic Aneurysm, Peripheral Artery Disease, Abdominal Aortic Aneurysm (AAA), Stent Placement, and Carotid Artery Surgery.

Jonathan S. Deitch
Distinguished in Median Arcuate Ligament Syndrome (MALS)
Dr. Jonathan S. Deitch
Vascular Surgery | General Surgery
Distinguished in Median Arcuate Ligament Syndrome (MALS)
Dr. Jonathan S. Deitch
Vascular Surgery | General Surgery

Texas Health Vascular Surgical Specialists

1325 Pennsylvania Ave, Ste 200, 
Fort Worth, TX 
 (32.7 miles away)
817-250-4235
Languages Spoken:
English
See accepted insurances

Dr. Jonathan Deitch has held academic and departmental leadership roles in the area of surgery since 1998. He previously served as associate professor of Surgery and associate chairman of Surgery at Staten Island University Hospital in New York for more than a decade. He also has held numerous academic appointments in vascular surgery, including Chief of Vascular And Endovascular Surgery and the program director of vascular fellowship in the Department of Surgery at Staten Island University Hospital. Dr. Deitch currently serves as Professor of Surgery at the Burnett School of Medicine at Texas Christian University in Fort Worth. Dr. Deitch is fellowship-trained in vascular and endovascular surgery. He is a Fellow of the American College of Surgeons, a member of the Society of Vascular Surgery, southern Association of Vascular Surgery, the Eastern Vascular Society and the Society of Clinical Vascular Surgery. Dr. Deitch performs a broad range of open and minimally invasive procedures to promote improved circulatory health beyond abdominal aortic aneurysms, venous thrombosis, peripheral vascular disease, carotid artery disease, and other vascular conditions. Additionally, he focuses on the care of vascular trauma patients and those with comorbidities related to diabetes.Dr. Deitch earned his medical degree at New York Medical College in Valhalla. He completed his general surgery residency at Montefiore Medical Center/Albert Einstein College of Medicine in The Bronx, N.Y. He served as chief resident during his final year in residency. Dr. Deitch went on to complete his vascular surgery fellowship at Wake Forest University School of Medicine in Winston-Salem, N.C., and his endovascular surgery fellowship at the University of Medicine and Dentistry of New Jersey in Newark.Dr. Deitch has served as an investigator for a variety of clinical trials in vascular procedures and treatments, and has published extensively in the field of vascular surgery. He was repeatedly recognized as a top physician and surgeon in the New York area prior to relocating to Texas. Dr. Deitch is rated as a Distinguished provider by MediFind in the treatment of Median Arcuate Ligament Syndrome (MALS). His top areas of expertise are Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm, Carotid Artery Disease, Carotid Artery Surgery, and Aneurysm Repair.

VIEW MORE MEDIAN ARCUATE LIGAMENT SYNDROME (MALS) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Celinski's expertise for a condition
ConditionClose
    • Distinguished
    • Pancreatic Cancer
      Dr. Celinski is
      Distinguished
      . Learn about Pancreatic Cancer.
      See more Pancreatic Cancer experts
    • Advanced
    • Cholangiocarcinoma (Bile Duct Cancer)
      Dr. Celinski is
      Advanced
      . Learn about Cholangiocarcinoma (Bile Duct Cancer).
      See more Cholangiocarcinoma (Bile Duct Cancer) experts
    • Familial Pancreatic Cancer
      Dr. Celinski is
      Advanced
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Pancreatectomy
      Dr. Celinski is
      Advanced
      . Learn about Pancreatectomy.
      See more Pancreatectomy experts
    • Pancreaticoduodenectomy
      Dr. Celinski is
      Advanced
      . Learn about Pancreaticoduodenectomy.
      See more Pancreaticoduodenectomy experts
    • Pseudomyxoma Peritonei
      Dr. Celinski is
      Advanced
      . Learn about Pseudomyxoma Peritonei.
      See more Pseudomyxoma Peritonei experts
    • Small Bowel Resection
      Dr. Celinski is
      Advanced
      . Learn about Small Bowel Resection.
      See more Small Bowel Resection experts
    View All 7 Advanced Conditions
    • Experienced
    • Adrenal Cancer
      Dr. Celinski is
      Experienced
      . Learn about Adrenal Cancer.
      See more Adrenal Cancer experts
    • Adrenocortical Carcinoma
      Dr. Celinski is
      Experienced
      . Learn about Adrenocortical Carcinoma.
      See more Adrenocortical Carcinoma experts
    • Ampullary Cancer
      Dr. Celinski is
      Experienced
      . Learn about Ampullary Cancer.
      See more Ampullary Cancer experts
    • Bile Duct Stricture
      Dr. Celinski is
      Experienced
      . Learn about Bile Duct Stricture.
      See more Bile Duct Stricture experts
    • BRCA Positive Breast Cancer
      Dr. Celinski is
      Experienced
      . Learn about BRCA Positive Breast Cancer.
      See more BRCA Positive Breast Cancer experts
    • Childhood Pancreatitis
      Dr. Celinski is
      Experienced
      . Learn about Childhood Pancreatitis.
      See more Childhood Pancreatitis experts
    View All 56 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.